Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Apex MD vs Direct Meds

By GLP-1 ScorecardUpdated

Apex MD
Site position #96

Lower grade

Direct Meds
Site position #35

Higher grade

Score comparison

Direct Meds has the higher recorded score — 77.6/100 to 71.8/100.

Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueDirect Meds +37
48
85
Dose & formulationDirect Meds +5
83
88
Clinical oversightApex MD +23
78
55
Labs & monitoringApex MD +11
89
78
FulfillmentApex MD +2
82
80
Contract termsDirect Meds +25
55
80
Apex MD · top barDirect Meds · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricApex MDDirect Meds
WeighScore71.8/10077.6/100
GradeCC+
Site position#96#35
Semaglutide$299/mo$249/30 days sublingual · $297/mo injectable
Tirzepatide$399/mo$299/30 days sublingual · $399/mo injectable
CoverageAll 50 statesNot publicly listed
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Apex MD

Site position #96 · C

Strengths

  • Licensed in all 50 states
  • Unlimited provider visits and Labcorp labs included in the plan
  • Both semaglutide and tirzepatide, injectable or oral
  • Medication delivery typically in under four business days

What to consider

  • Compounds bundle NAD, B-12 and L-Carnitine rather than a single-ingredient GLP-1
  • Does not publicly name its compounding pharmacy or list an accreditation seal
Direct Meds

Site position #35 · C+

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Strengths

  • Injection and sublingual preparations have separately published prices
  • Pricing page advertises medication, evaluation, supplies, shipping and nurse access
  • Both semaglutide and tirzepatide are listed
  • Checked semaglutide campaign states $147 initially, then $297 monthly

What to consider

  • Compounded preparations are not FDA-approved products or assumed equivalent across routes
  • No-subscription FAQ wording conflicts with the agreement's 30-day recurring charges
  • Renewal cancellation requires 48-hour notice; initial-order cancellation has a separate conditional 24-hour window
  • Assigned prescribing practice, dispensing pharmacy and selected longer-plan total need confirmation
  • Checked campaign excludes Mississippi and Louisiana; confirm state eligibility

Featured provider

Direct Meds

Direct Meds scores 77.6/100 (C+). Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard